FindMyKOL
Clinical trialNCT01203358CompletedPhase 2, PHASE3Interventional

Exosurf Neonatal and Survanta for Treatment of Respiratory Distress Syndrome

SponsorNICHD Neonatal Research NetworkEnrollment617Bronchopulmonary DysplasiaInfant, Low Birth WeightInfant, NewbornInfant, PrematureInfant, Small for Gestational Age
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to compare the efficacy of two surfactants, Exosurf Neonatal (Burroughs Wellcome Co.) and Survanta (Ross Laboratories), for the treatment of neonatal respiratory distress syndrome.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Stanford University

    Palo Alto, California, United States

  • Yale University

    New Haven, Connecticut, United States

  • George Washington University

    Washington D.C., District of Columbia, United States

  • University of Miami

    Miami, Florida, United States

  • Emory University

    Atlanta, Georgia, United States

  • Indiana University

    Indianapolis, Indiana, United States

  • Wayne State University

    Detroit, Michigan, United States

  • University of New Mexico

    Albuquerque, New Mexico, United States

  • Cincinnati Children'S Medical Center

    Cincinnati, Ohio, United States

  • Case Western Reserve University, Rainbow Babies and Children'S Hospital

    Cleveland, Ohio, United States

  • University of Tennessee

    Memphis, Tennessee, United States

  • University of Texas Southwestern Medical Center at Dallas

    Dallas, Texas, United States

  • University of Vermont

    Burlington, Vermont, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

ExosurfSurvanta
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Jan 1991
Primary completion
31 Jan 1992
Completion
31 Jan 1992
Last update posted
22 Mar 2019
Registered enrollment
617
Registry id
NCT01203358

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 11 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.